RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Hypoxic pulmonary vasoconstriction and vascular contractility in monocrotaline-induced pulmonary arterial hypertensive rats

      한글로보기

      https://www.riss.kr/link?id=A103570925

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Pulmonary arterial hypertension (PAH) is a progressive disease characterized by vascular remodeling of pulmonary arteries (PAs) and increased vascular resistance in the lung. Monocrotaline (MCT), a toxic alkaloid, is widely used for developing rat models of PAH caused by injury to pulmonary endothelial cells; however, characteristics of vascular functions in MCT-induced PAH vary and are not fully understood. Here, we investigated hypoxic pulmonary vasoconstriction (HPV) responses and effects of various vasoconstrictors with isolated/perfused lungs of MCT-induced PAH (PAH-MCT) rats. Using hematoxylin and eosin staining, we confirmed vascular remodeling (i.e., medial thickening of PA) and right ventricle hypertrophy in PAH-MCT rats. The basal pulmonary arterial pressure (PAP) and PAP increase by a raised flow rate (40 mL/min) were higher in the PAH-MCT than in the control rats. In addition, both high K+ (40 mM KCl)- and angiotensin II-induced PAP increases were higher in the PAH-MCT than in the control rats. Surprisingly, application of a nitric oxide synthase inhibitor, L-NG-Nitroarginine methyl ester (L-NAME), induced a marked PAP increase in the PAH-MCT rats, suggesting that endothelial functions were recovered in the three-week PAH-MCT rats. In addition, the medial thickening of the PA was similar to that in chronic hypoxia-induced PAH (PAH-CH) rats. However, the HPV response (i.e., PAP increased by acute hypoxia) was not affected in the MCT rats, whereas HPV disappeared in the PAH-CH rats. These results showed that vascular contractility and HPV remain robust in the MCT-induced PAH rat model with vascular remodeling.
      번역하기

      Pulmonary arterial hypertension (PAH) is a progressive disease characterized by vascular remodeling of pulmonary arteries (PAs) and increased vascular resistance in the lung. Monocrotaline (MCT), a toxic alkaloid, is widely used for developing rat mod...

      Pulmonary arterial hypertension (PAH) is a progressive disease characterized by vascular remodeling of pulmonary arteries (PAs) and increased vascular resistance in the lung. Monocrotaline (MCT), a toxic alkaloid, is widely used for developing rat models of PAH caused by injury to pulmonary endothelial cells; however, characteristics of vascular functions in MCT-induced PAH vary and are not fully understood. Here, we investigated hypoxic pulmonary vasoconstriction (HPV) responses and effects of various vasoconstrictors with isolated/perfused lungs of MCT-induced PAH (PAH-MCT) rats. Using hematoxylin and eosin staining, we confirmed vascular remodeling (i.e., medial thickening of PA) and right ventricle hypertrophy in PAH-MCT rats. The basal pulmonary arterial pressure (PAP) and PAP increase by a raised flow rate (40 mL/min) were higher in the PAH-MCT than in the control rats. In addition, both high K+ (40 mM KCl)- and angiotensin II-induced PAP increases were higher in the PAH-MCT than in the control rats. Surprisingly, application of a nitric oxide synthase inhibitor, L-NG-Nitroarginine methyl ester (L-NAME), induced a marked PAP increase in the PAH-MCT rats, suggesting that endothelial functions were recovered in the three-week PAH-MCT rats. In addition, the medial thickening of the PA was similar to that in chronic hypoxia-induced PAH (PAH-CH) rats. However, the HPV response (i.e., PAP increased by acute hypoxia) was not affected in the MCT rats, whereas HPV disappeared in the PAH-CH rats. These results showed that vascular contractility and HPV remain robust in the MCT-induced PAH rat model with vascular remodeling.

      더보기

      참고문헌 (Reference)

      1 Zhang S, "Upregulation of Na+/Ca2+exchanger contributes to the enhanced Ca2+ entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension" 292 : 2297-2305, 2007

      2 Bogaard HJ, "The right ventricle under pressure : cellular and molecular mechanisms of right-heart failure in pulmonary hypertension" 135 : 794-804, 2009

      3 Gomez-Arroyo JG, "The monocrotaline model of pulmonary hypertension in perspective" 302 : 363-369, 2012

      4 Galié N, "The endothelin system in pulmonary arterial hypertension" 61 : 227-237, 2004

      5 Waypa GB, "Superoxide generated at mitochondrial complex III triggers acute responses to hypoxia in the pulmonary circulation" 187 : 424-432, 2013

      6 Yoo HY, "Role of thromboxane A2-activated nonselective cation channels in hypoxic pulmonary vasoconstriction of rat" 302 : 307-317, 2012

      7 Mathew R, "Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension" 82 : 1493-1498, 1997

      8 Schwenke DO, "Role of Rho-kinase signaling and endothelial dysfunction in modulating blood flow distribution in pulmonary hypertension" 110 : 901-908, 2011

      9 van Suylen RJ, "Pulmonary artery remodeling differs in hypoxia-and monocrotaline-induced pulmonary hypertension" 157 : 1423-1428, 1998

      10 Wilkins MR, "Pulmonary arterial hypertension" IOS Press 57-69, 2010

      1 Zhang S, "Upregulation of Na+/Ca2+exchanger contributes to the enhanced Ca2+ entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension" 292 : 2297-2305, 2007

      2 Bogaard HJ, "The right ventricle under pressure : cellular and molecular mechanisms of right-heart failure in pulmonary hypertension" 135 : 794-804, 2009

      3 Gomez-Arroyo JG, "The monocrotaline model of pulmonary hypertension in perspective" 302 : 363-369, 2012

      4 Galié N, "The endothelin system in pulmonary arterial hypertension" 61 : 227-237, 2004

      5 Waypa GB, "Superoxide generated at mitochondrial complex III triggers acute responses to hypoxia in the pulmonary circulation" 187 : 424-432, 2013

      6 Yoo HY, "Role of thromboxane A2-activated nonselective cation channels in hypoxic pulmonary vasoconstriction of rat" 302 : 307-317, 2012

      7 Mathew R, "Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension" 82 : 1493-1498, 1997

      8 Schwenke DO, "Role of Rho-kinase signaling and endothelial dysfunction in modulating blood flow distribution in pulmonary hypertension" 110 : 901-908, 2011

      9 van Suylen RJ, "Pulmonary artery remodeling differs in hypoxia-and monocrotaline-induced pulmonary hypertension" 157 : 1423-1428, 1998

      10 Wilkins MR, "Pulmonary arterial hypertension" IOS Press 57-69, 2010

      11 Archer SL, "Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction : ionic diversity in smooth muscle cells" 95 : 308-318, 2004

      12 Osipenko ON, "Potential role for kv3.1b channels as oxygen sensors" 86 : 534-540, 2000

      13 Zhao LR, "Multiphoton microscope imaging : the behavior of neural progenitor cells in the rostral migratory stream" 425 : 83-88, 2007

      14 de Jesus Perez VA, "Molecular pathogenesis and current pathology of pulmonary hypertension" 21 : 239-257, 2016

      15 Leopold JA, "Molecular mechanisms of pulmonary vascular remodeling in pulmonary arterial hypertension" 17 : 761-, 2016

      16 Pozeg ZI, "In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats" 107 : 2037-2044, 2003

      17 Stenmark KR, "Hypoxia-induced pulmonary vascular remodeling : cellular and molecular mechanisms" 99 : 675-691, 2006

      18 Kay JM, "Failure to show decrease in small pulmonary blood vessels in rats with experimental pulmonary hypertension" 37 : 927-930, 1982

      19 Schwenke DO, "Exogenous ghrelin improves blood flow distribution in pulmonary hypertension-assessed using synchrotron radiation microangiography" 462 : 397-406, 2011

      20 Frasch HF, "Endothelin-1 is elevated in monocrotaline pulmonary hypertension" 276 : 304-310, 1999

      21 Liu CP, "Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model" 30 : 267-278, 2014

      22 Sakao S, "Endothelial cells and pulmonary arterial hypertension : apoptosis, proliferation, interaction and transdifferentiation" 10 : 95-, 2009

      23 Chuang IC, "Effect of carbon dioxide inhalation on pulmonary hypertension induced by increased blood flow and hypoxia" 27 : 336-343, 2011

      24 de Man FS, "Dysregulated renin-angiotensinaldosterone system contributes to pulmonary arterial hypertension" 186 : 780-789, 2012

      25 Weissmann N, "Downregulation of hypoxic vasoconstriction by chronic hypoxia in rabbits : effects of nitric oxide" 284 : 931-938, 2003

      26 유해영, "Disappearance of Hypoxic Pulmonary Vasoconstriction and O2-Sensitive Nonselective Cationic Current in Arterial Myocytes of Rats Under Ambient Hypoxia" 대한약리학회 17 (17): 463-468, 2013

      27 Barst RJ, "Diagnosis and differential assessment of pulmonary arterial hypertension" 43 (43): 40-47, 2004

      28 Morimatsu Y, "Development and characterization of an animal model of severe pulmonary arterial hypertension" 49 : 33-42, 2012

      29 Sumpio BE, "Cells in focus : endothelial cell" 34 : 1508-1512, 2002

      30 Fagan KA, "Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase" 287 : 656-664, 2004

      31 Stenmark KR, "Animal models of pulmonary arterial hypertension : the hope for etiological discovery and pharmacological cure" 297 : 1013-1032, 2009

      32 Colvin KL, "Animal Models of Pulmonary Hypertension : Matching Disease Mechanisms to Etiology of the Human Disease" 4 : 198-, 2014

      33 Reeve HL, "Alterations in a redox oxygen sensing mechanism in chronic hypoxia" 90 : 2249-2256, 2001

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-04-29 학술지명변경 외국어명 : THE KOREAN JOURNAL OF Physiology & Pharmacology -> The Korean Journal of Physiology & Pharmacology KCI등재
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-10-12 학술지명변경 한글명 : 대한 생리.약리학회지 -> The Korean Journal of Physiology & Pharmacology
      외국어명 : THE KOREAN JOURNAL OF Physilogy & Pharmacology -> THE KOREAN JOURNAL OF Physiology & Pharmacology
      KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2001-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.85 0.36 1.29
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.05 0.9 0.575 0.09
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼